Johnson & Johnson/Janssen COVID-19 Vaccine and Cerebral Venous Sinus Thrombosis with Thrombocytopenia – Update for Clinicians on Early Detection and Treatment

Details

• Personal Author:
  Oliver, Sara E. ; Shimabukuro, Tom T.
• Corporate Authors:
  United States. Advisory Committee on Immunization Practices. COVID-19 Vaccines Work Group. ; CDC COVID-19 Response Team.
• Description:
  Thursday, April 15, 2021
  
  Time: 2:00 PM – 3:00 PM ET
  
  This COCA Call will present the latest evidence on cerebral venous sinus thrombosis (CVST) with thrombocytopenia associated with the administration of the Johnson & Johnson/Janssen COVID-19 vaccine. Speakers will discuss what is known about CVST, the importance of early detection, and updated vaccine recommendations.
  
  041521_slide.pdf
  
  ACIP Influenza Vaccination Updates for the 2020–21 Season / Lisa Grohskopf -- Standards for Adult Immunization and Vaccination Guidance during the COVID-19 Pandemic / Tara Jatlaoui -- Flu vaccination planning and guidance for vaccination clinics in satellite, temporary, or off-site locations / Amy Parker Fiebelkorn.
  
  
• Subjects:
  Cerebral Veins Coronavirus Infections/prevention & Control COVID-19 Vaccines COVID-19/prevention & Control Sinus Thrombosis, Intracranial
• Series:
  Clinician Outreach and Communication Activity (COCA) Webinar
• Document Type:
  Text
• Name as Subject:
  Janssen COVID-19 vaccine ; Janssen COVID-19 vaccine
• Genre:
  Webinar
• Place as Subject:
  United States
• Collection(s):
  Stephen B. Thacker CDC Library
• Main Document Checksum:
  urn:sha-512:ef4131aac5156af55ebbf6b784bad6fdcb4e214201cf64cc1213fee3cc3414a6da3a98813ff351b40f6c5198e01e8605403f43cb2157ddcf676c1d07e91f9a00
• Download URL:
  https://stacks.cdc.gov/view/cdc/105202/cdc_105202_DS1.pdf
• File Type:
  [PDF - 1.68 MB ]